The recent revolution in our understanding of biochemical genetics has radically altered the simple concepts that held sway“only yesterday.”Correspondingly, our appreciation of the complexity and variety of mutation has begun to provide a biochemical rationale for much of the clinical heterogeneity observed in many genetic diseases—e.g., the beta-thalassemias.